ATE468864T1 - Arzneimittel gegen hörfunktionsstörungen - Google Patents

Arzneimittel gegen hörfunktionsstörungen

Info

Publication number
ATE468864T1
ATE468864T1 AT03748683T AT03748683T ATE468864T1 AT E468864 T1 ATE468864 T1 AT E468864T1 AT 03748683 T AT03748683 T AT 03748683T AT 03748683 T AT03748683 T AT 03748683T AT E468864 T1 ATE468864 T1 AT E468864T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
medicinal products
hearing impairment
hearing disorders
gene therapy
Prior art date
Application number
AT03748683T
Other languages
English (en)
Inventor
Yasufumi Kaneda
Kazuo Oshima
Ryuichi Morishita
Takeshi Kubo
Original Assignee
Anges Mg Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anges Mg Inc filed Critical Anges Mg Inc
Application granted granted Critical
Publication of ATE468864T1 publication Critical patent/ATE468864T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03748683T 2002-10-02 2003-10-02 Arzneimittel gegen hörfunktionsstörungen ATE468864T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002289639 2002-10-02
PCT/JP2003/012674 WO2004030702A1 (ja) 2002-10-02 2003-10-02 聴覚機能障害用医薬

Publications (1)

Publication Number Publication Date
ATE468864T1 true ATE468864T1 (de) 2010-06-15

Family

ID=32063748

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03748683T ATE468864T1 (de) 2002-10-02 2003-10-02 Arzneimittel gegen hörfunktionsstörungen

Country Status (9)

Country Link
US (1) US7390482B2 (de)
EP (1) EP1547618B1 (de)
JP (1) JP4533144B2 (de)
CN (1) CN1703248A (de)
AT (1) ATE468864T1 (de)
AU (1) AU2003268741B2 (de)
CA (1) CA2500278A1 (de)
DE (1) DE60332748D1 (de)
WO (1) WO2004030702A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2211182A1 (de) 2009-01-16 2010-07-28 Roche Diagnostics GmbH Verfahren zur Bewertung des Schweregrades einer Leberzirrhose
EP4045092A1 (de) * 2019-10-18 2022-08-24 Research Institute at Nationwide Children's Hospital Zielgerichtete cochlear-zellen-gentherapie
CN116440274A (zh) * 2023-03-17 2023-07-18 烟台毓璜顶医院(青岛大学附属烟台毓璜顶医院) c-MET及其激活剂的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136785A (en) 1995-08-08 2000-10-24 University Of Virginia Patent Foundation Protection from loss of sensory hair cells in the inner ear by administration of insulin-like growth factor and platelet derived growth factor
KR100765687B1 (ko) * 1995-08-29 2007-10-11 안제스에무지 가부시키가이샤 Ｈｇｆ 유전자를 함유하는 약제
US5929041A (en) * 1996-02-23 1999-07-27 Amgen Inc. Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
AU3591597A (en) 1996-06-28 1998-01-21 Regents Of The University Of California, The Transformation and genetherapy of cells of the inner ear
US6593290B1 (en) * 1996-11-01 2003-07-15 Genentech, Inc. Treatment of inner ear hair cells
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product
DE19807426A1 (de) 1998-02-23 1999-10-14 Otogene Biotechnologische Fors Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs
US6017886A (en) 1998-08-05 2000-01-25 Amgen Inc. Use of NDF peptide as growth factor for sensory epithelium
CA2361289A1 (en) 1999-03-18 2000-09-21 The Regents Of The University Of California Compositions for promoting nerve regeneration
KR20010093804A (ko) 1999-10-08 2001-10-29 무라야마 마사노리 심근증 유전자 치료
EP1142590B8 (de) 1999-10-29 2008-11-26 AnGes MG, Inc. Gentherapie für diabetische ischämie
CN1142272C (zh) * 2000-02-02 2004-03-17 中国人民解放军军事医学科学院百环生物医学研究中心 携带人肝细胞生长因子基因的重组腺病毒的用途
JP5442173B2 (ja) 2000-09-14 2014-03-12 敏一 中村 筋萎縮性側索硬化症治療剤
US20030176347A1 (en) 2003-05-14 2003-09-18 Toshikazu Nakamura Remedies for amyotrophic lateral sclerosis
CN1150035C (zh) * 2000-12-21 2004-05-19 中国人民解放军军事医学科学院放射医学研究所 一种重组质粒及其在疾病防治中的应用

Also Published As

Publication number Publication date
CA2500278A1 (en) 2004-04-15
DE60332748D1 (de) 2010-07-08
CN1703248A (zh) 2005-11-30
JPWO2004030702A1 (ja) 2006-01-26
JP4533144B2 (ja) 2010-09-01
EP1547618B1 (de) 2010-05-26
EP1547618A4 (de) 2007-10-10
US20060233755A1 (en) 2006-10-19
US7390482B2 (en) 2008-06-24
WO2004030702A1 (ja) 2004-04-15
AU2003268741A1 (en) 2004-04-23
AU2003268741B2 (en) 2009-06-11
EP1547618A1 (de) 2005-06-29

Similar Documents

Publication Publication Date Title
TNSN08079A1 (en) Pharmaceutical compositions for the treatment of inner ear disorders
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
FR13C0012I1 (de)
DK1256339T3 (da) Transdermalt terapeutisk system for opnåelse af høje plasmaniveauer af rotigotin i behandlingen af Parkinsons sygdom
ECSP083351A (es) Composiciones farmacéuticas
NO20006328D0 (no) Attenuerte negative trådvirus med endret interferonantagonistaktivitet for anvendelse som vaksiner og medikamenter
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
WO2004016248A3 (fr) Forme galenique pour la delivrance colique de principes actifs
MXPA04000920A (es) Derivados de aminoisoxazol activos como inhibidores de la cinasa.
BRPI0311701B8 (pt) formulação farmacêutica de dosagem multiparticulada revestida com liberação controlada de lamotrigina
NO20081844L (no) Terapeutiske forbindelser
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
NO20060991L (no) Feksofenadinsammensetning og fremgangsmate til fremstilling
EA200600603A1 (ru) Оральная система доставки лекарственного препарата
AU2003293593A1 (en) Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration
WO2005055955A3 (en) DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
NO20064521L (no) Framgangsmate og blanding for behandling av rhinitt
DE60102590T2 (de) Darreichungsformen zur behandlung von oralen mykosen
EA200501697A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
CY1105408T1 (el) Χρησιμοποιηση στελεχων του ιου parapox ovis για την παρασκευη αντιικων φαρμακων και φαρμακων κατα του καρκινου
ATE468864T1 (de) Arzneimittel gegen hörfunktionsstörungen
PL370412A1 (en) Pseudopolymorphic forms of carvedilol
AU2002322082A1 (en) Pharmaceutical composition for the treatment of viral infection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties